Intl Fcstone »

Bioxcel Therapeutics shares owned by Intl Fcstone

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Intl Fcstone from 13F filings

Historical chart of Intl Fcstone investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Intl Fcstone consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Intl Fcstone

Quarter filed Position value Share count Share price at filing
2026-06-30 $29k 21k 1.41

More positions owned by Intl Fcstone

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Val Etf (IWD)
Schwab Strategic Tr Fundamental Intl (FNDF)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Victory Portfolios Ii Shs Fr Ca Fl Etf (VFLO)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Rus 1000 Grw Etf (IWF)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr Msci Eafe Etf (EFA)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)

View all positions for Intl Fcstone

Top funds holding Bioxcel Therapeutics

Millennium Management
Oaktree Capital Management
Vanguard Capital Management
Oaktree Fund Advisors
Geode Capital Management
BlackRock
UBS Group
Citadel Advisors
Vanguard Fiduciary Trust
State Street Corporation
FMR
Wiley Bros.-aintree Capital
Jones Financial Companies, L.L
Northern Trust
HighTower Advisors

View all funds holding Bioxcel Therapeutics